SPHINX

Spontaneous clearance in patients with acute HCV infection: immune profiling, biomarkers and x-omics technologies

Description

In SPHINX, the spontaneous clearance of HC viruses will be investigated using x-Omics technologies. For this purpose, (1) plasma profiles are created, (2) the HCV-specific cellular immune responses are examined during the clearance phase and (3) genetic and epigenetic variations are searched for to predict viral clearance. The focus of the investigations is primarily on the HCV genotype 4.

Period:
01.11.2010 - 30.04.2014
FKZ:
261365
Management:
FP7-Health

Projectlead

Dr. Nicole Schneiderhan-Marra

Head of Pharma & Biotech